Literature DB >> 25099026

Mesoporous silica supraparticles for sustained inner-ear drug delivery.

Yajun Wang1, Andrew K Wise, Justin Tan, James W Maina, Robert K Shepherd, Frank Caruso.   

Abstract

Mesoporous silica supraparticles (MS-SPs) are prepared via self-assembly of mesoporous silica nanoparticles under capillary force action in confined droplets. The MS-SPs are effective carriers for sustained drug delivery. Animal studies show that these particles are suitable for chronic intracochlear implantation, and neurotrophins released from the MS-SPs can efficiently rescue primary auditory neurons in an in vivo sensorineural hearing loss model.
© 2014 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  drug delivery; mesoporous materials; neurotrophic factors; sensorineural hearing loss; supraparticles

Mesh：

Substances：

Year:  2014        PMID： 25099026     DOI： 10.1002/smll.201401767

Source DB:  PubMed          Journal:  Small        ISSN： 1613-6810            Impact factor:   13.281


  12 in total

Review 1.  Animal model studies yield translational solutions for cochlear drug delivery.

Authors:  R D Frisina; M Budzevich; X Zhu; G V Martinez; J P Walton; D A Borkholder
Journal:  Hear Res       Date:  2018-05-05       Impact factor: 3.208

Review 2.  Self-Assembled Nanoscale Materials for Neuronal Regeneration: A Focus on BDNF Protein and Nucleic Acid Biotherapeutic Delivery.

Authors:  Yu Wu; Miora Rakotoarisoa; Borislav Angelov; Yuru Deng; Angelina Angelova
Journal:  Nanomaterials (Basel)       Date:  2022-06-30       Impact factor: 5.719

Review 3.  Current Concepts and Future Trends in Increasing the Benefits of Cochlear Implantation: A Narrative Review.

Authors:  Cristina Maria Blebea; Laszlo Peter Ujvary; Violeta Necula; Maximilian George Dindelegan; Maria Perde-Schrepler; Mirela Cristina Stamate; Marcel Cosgarea; Alma Aurelia Maniu
Journal:  Medicina (Kaunas)       Date:  2022-05-31       Impact factor: 2.948

Review 4.  New molecular therapies for the treatment of hearing loss.

Authors:  Yutian Ma; Andrew K Wise; Robert K Shepherd; Rachael T Richardson
Journal:  Pharmacol Ther       Date:  2019-05-08       Impact factor: 12.310

5.  Improved Auditory Nerve Survival with Nanoengineered Supraparticles for Neurotrophin Delivery into the Deafened Cochlea.

Authors:  Andrew K Wise; Justin Tan; Yajun Wang; Frank Caruso; Robert K Shepherd
Journal:  PLoS One       Date:  2016-10-27       Impact factor: 3.240

6.  Bioreducible Hydrophobin-Stabilized Supraparticles for Selective Intracellular Release.

Authors:  Daniele Maiolo; Claudia Pigliacelli; Paola Sánchez Moreno; Martina Bruna Violatto; Laura Talamini; Ilaria Tirotta; Rosanna Piccirillo; Massimo Zucchetti; Lavinia Morosi; Roberta Frapolli; Gabriele Candiani; Paolo Bigini; Pierangelo Metrangolo; Francesca Baldelli Bombelli
Journal:  ACS Nano       Date:  2017-08-17       Impact factor: 15.881

Review 7.  Nanomedicine for Inner Ear Diseases: A Review of Recent In Vivo Studies.

Authors:  Dong-Kee Kim
Journal:  Biomed Res Int       Date:  2017-10-10       Impact factor: 3.411

Review 8.  Combination of cell-penetrating peptides with nanomaterials for the potential therapeutics of central nervous system disorders: a review.

Authors:  Ying Zhang; Pan Guo; Zhe Ma; Peng Lu; Dereje Kebebe; Zhidong Liu
Journal:  J Nanobiotechnology       Date:  2021-08-23       Impact factor: 10.435

9.  Long-term delivery of brain-derived neurotrophic factor (BDNF) from nanoporous silica nanoparticles improves the survival of spiral ganglion neurons in vitro.

Authors:  Nadeschda Schmidt; Jennifer Schulze; Dawid P Warwas; Nina Ehlert; Thomas Lenarz; Athanasia Warnecke; Peter Behrens
Journal:  PLoS One       Date:  2018-03-27       Impact factor: 3.240

10.  A Review of Gene, Drug and Cell-Based Therapies for Usher Syndrome.

Authors:  Lucy S French; Carla B Mellough; Fred K Chen; Livia S Carvalho
Journal:  Front Cell Neurosci       Date:  2020-07-09       Impact factor: 5.505
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.